Bio-IT World November 25, 2024
Answer ALS and Cedars-Sinai have announced the completed availability of the largest ALS patient-based induced pluripotent stem cell and bio data repository; Scale Biosciences and Revvity’s business, BioLegend, announced the availability of a first-of-its-kind TotalSeq Phenocyte single-cell protein profiling solution that supports customers by more easily identifying and characterizing rare cell subtypes; ChapsVision has acquired Sinequa; and more.
ChapsVision has acquired Sinequa. This strategic acquisition and a $90 million investment led by Tikehau Capital and others will enhance ChapsVision’s ArgonOS platform, combining advanced search and data processing capabilities that support clients’ digital needs in industries, such as manufacturing, life sciences, and financial services, as well as aerospace and defense. As Sinequa serves many prestigious clients, including...
Today's Sponsors
Today's Sponsor